attention deficit hyperactivity disorder therapy (Advinus/P2D Bioscience)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameattention deficit hyperactivity disorder therapy (Advinus/P2D Bioscience)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEurofins Advinus Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesP2D BiosciencesEurofins Advinus Ltd
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A